{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:06:35Z","timestamp":1790816795016,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.abd.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T08:31:07Z","timestamp":1637915467000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-6637","authenticated-orcid":false,"given":"William Queiroz Guimar\u00e3es Wiegandt","family":"Ceglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-1114","authenticated-orcid":false,"given":"Marina Mattos","family":"Rebeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-7247","authenticated-orcid":false,"given":"Marcela Ferreira","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1959-4908","authenticated-orcid":false,"given":"Denis","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-4311","authenticated-orcid":false,"given":"Jade","family":"Cury-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-092X","authenticated-orcid":false,"given":"Jos\u00e9 Ant\u00f4nio","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.05.007_bib0005","unstructured":"Inca.gov [Internet]. Brasil: Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva. Estimativa 2020: incid\u00eancia de c\u00e2ncer no Brasil. [cited 2020 Mar 01]. Available from: https:\/\/www.inca.gov.br\/estimativa."},{"key":"10.1016\/j.abd.2021.05.007_bib0010","unstructured":"Datasus.gov [Internet]. Brasil: Minist\u00e9rio da Sa\u00fade. Departamento de Inform\u00e1tica do SUS - DATASUS. Informa\u00e7\u00f5es de Sa\u00fade (TabNet), Estat\u00edsticas Vitais 2018. [cited 2020 May 25]. Available from: http:\/\/www2.datasus.gov.br\/DATASUS\/index.php?area=02."},{"key":"10.1016\/j.abd.2021.05.007_bib0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2010.06.051","article-title":"The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies","volume":"65","author":"Balagula","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/ijd.IJD_65_17","article-title":"Cutaneous Adverse Reactions of Chemotherapy in Cancer Patients: A Clinicoepidemiological Study","volume":"63","author":"Biswal","year":"2018","journal-title":"Indian J Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0025","first-page":"267","article-title":"Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women\u2019s cancers. Results of a prospective study","volume":"16","author":"Hackbarth","year":"2008","journal-title":"Support Care Cancer."},{"key":"10.1016\/j.abd.2021.05.007_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14740338.3.6.579","article-title":"Mucocutaneous side effects of antineoplastic chemotherapy","volume":"3","author":"Guillot","year":"2004","journal-title":"Expert Opin Drug Saf."},{"key":"10.1016\/j.abd.2021.05.007_bib0040","unstructured":"nih.gov [Internet]. EUA: National Institute of Health. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. November 27, 2017. Acesso em: 14 de jan. de 2020."},{"key":"10.1016\/j.abd.2021.05.007_bib0045","unstructured":"cancer.org [Internet]. Atlanta: American Cancer Society medical and editorial content team. Treatment & Support [Internet]. American Cancer Societ. Available From: https:\/\/www.cancer.org\/cancer\/acs-medical-content-and-news-staff.html."},{"key":"10.1016\/j.abd.2021.05.007_bib0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.abd.2020.01.001","article-title":"Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel","volume":"95","author":"Cury-Martins","year":"2020","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaad.2006.09.005","article-title":"Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management","volume":"56","author":"Hu","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","article-title":"Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management","volume":"71","author":"Miller","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000371821","article-title":"Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights","volume":"1","author":"Fabbrocini","year":"2015","journal-title":"Skin Appendage Disord."},{"key":"10.1016\/j.abd.2021.05.007_bib0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clindermatol.2011.08.032","article-title":"Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts","volume":"29","author":"Choi","year":"2011","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/02841860701765675","article-title":"Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis","volume":"47","author":"Chu","year":"2008","journal-title":"Acta Oncol."},{"key":"10.1016\/j.abd.2021.05.007_bib0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1634\/theoncologist.2008-0237","article-title":"Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs)","volume":"14","author":"Anderson","year":"2009","journal-title":"Oncologist."},{"key":"10.1016\/j.abd.2021.05.007_bib0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-4632.2005.02647.x","article-title":"Flagellate erythema","volume":"45","author":"Yamamoto","year":"2006","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ad.2018.10.019","article-title":"Adverse Hair Reactions to New Targeted Therapies for Cancer","volume":"110","author":"Mir-Bonaf\u00e9","year":"2019","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"key":"10.1016\/j.abd.2021.05.007_bib0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/S0365-05962010000500002","article-title":"Adverse mucocutaneous reactions related to chemotherapeutic agents: part II","volume":"85","author":"Criado","year":"2010","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2021.05.007_bib0100","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaad.2019.01.077","article-title":"Incidence and risk of developing photosensitivity with targeted anticancer therapies","volume":"81","author":"Ciccolini","year":"2019","journal-title":"J Am Acad Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036505962100252X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036505962100252X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:49Z","timestamp":1759794049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036505962100252X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S036505962100252X"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.05.007","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}